-
The approval to Covaxin has been questioned by industry experts and some opposition Congress leaders who have expressed concern over the absence of phase 3 trial data
-
The Brazilian Association of Vaccine Clinics (ABCVAC) confirmed on its website it had signed a memorandum of understanding with the Indian firm to purchase its Covaxin vaccine
-
The Nation's first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for the conduct of the Phase III clinical trials
-
"Following the emergency use permission, the company is in a position to meet any production requirement that the government may have at this time,” company officials said
-
While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the most. Covaxin has generated excellent safety data with robust immune responses
-
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV).
-
The development came after the UK became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, even as it battled the new highly contagious variant of the coronavirus.
-
CEPI will initially contribute up to $5 million towards the cost of scaling up the process for manufacturing the vaccine
-
We're grateful for all the scientists, researchers, manufacturing workers, and service members, who have worked tirelessly to make this breakthrough possible. It is truly a Christmas miracle, said the US president
-
The exercise will include necessary data entry in Co-WIN, an online platform for monitoring of vaccine delivery, testing receipt and allocation, deployment of team members, mock drill of session sites with test beneficiaries
-
Health Department has uploaded list of all the health care workers in COWIN application
-
All citizens over 80 years of age as well as residents and staff of nursing homes would be among the first to get vaccinated, Xinhua news agency quoted Spahn as saying at a press conference on Friday.
-
It also said that protective level of antibodies generally develop two weeks after receiving the second dose.
-
The European Union is under massive pressure to approve potential vaccines after Britain and the United States began rolling out a drug produced by Pfizer and BioNtech.
-
In the past week, the US, the worst-hit nation, has reported an average of more than 215,000 new infections a day.
-
The ministry opened registration for the vaccination campaign through an online application called "Sehaty", and said the vaccine would be "free for all citizens and residents".
-
A two-day training programme on identifying field level health care workers who will administer the vaccine and provide them training was inaugurated on Monday.
-
Pinarayi Vijayan had on Saturday said COVID-19 vaccine will be made available free of cost to all people in Kerala.
-
Trudeau has previously said the country will receive 249,000 initial doses of the vaccine this month, the first 30,000 doses of which are expected to have arrived by Monday.
-
Researchers at Check Point said they have found a stream of posts on the darknet from sources claiming to have a range of "coronavirus vaccines" or "coronavirus remedies" for sale.